CN101410398B — 碳青霉素烯化合物的改良制备方法
Assigned to Kaneka Corp · Expires 2013-01-23 · 13y expired
What this patent protects
本发明提供(4R,5S,6S)-3-[[(3S,5S)-5-(二甲基氨基羰基)-3-吡咯烷基]硫基]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-甲酸的简便制备方法,该化合物具有良好的抗菌活性。本发明涉及一种连续进行制备(4R,5S,6S)-3-[[(3S,5S)-5-(二甲基氨基羰基)-3-吡咯烷基]硫基]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-甲酸的方法,其不分离·精制中间产物。
USPTO Abstract
本发明提供(4R,5S,6S)-3-[[(3S,5S)-5-(二甲基氨基羰基)-3-吡咯烷基]硫基]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-甲酸的简便制备方法,该化合物具有良好的抗菌活性。本发明涉及一种连续进行制备(4R,5S,6S)-3-[[(3S,5S)-5-(二甲基氨基羰基)-3-吡咯烷基]硫基]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-甲酸的方法,其不分离·精制中间产物。
Drugs covered by this patent
- Nubeqa (darolutamide) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.